Potential interference of agents on radioiodide thyroid uptake in the euthyroid rat

Journal of Nuclear Medicine

Volumn 44, Issue 5, 2003, Pages 832-838

  Yu, Ming Der ^a   Shaw, Stanley M ^b,c  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b PURDUE UNIVERSITY   (United States)

^c PURDUE UNIVERSITY   (United States)

Author keywords

Euthyroid rat; Interfering agents; Radioiodide thyroid uptake

Indexed keywords

DIATRIZOATE; IOHEXOL; MEGLUMINE; POTASSIUM IODIDE; PROPYLTHIOURACIL; RADIOACTIVE IODINE; MEGLUMINE DIATRIZOATE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG UPTAKE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; THYROID GLAND; ANIMAL; DRUG EFFECT; METABOLISM; SPRAGUE DAWLEY RAT;

ANIMALS; DIATRIZOATE MEGLUMINE; IODINE RADIOISOTOPES; IOHEXOL; MALE; POTASSIUM IODIDE; PROPYLTHIOURACIL; RATS; RATS, SPRAGUE-DAWLEY; THYROID GLAND;

EID: 0037607421     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Harbert JC The thyroid. In: Harbert JC, Eckelman WC, Neumann RD, eds. Nuclear Medicine Diagnosis and Therapy New York, NY: Thieme Medical Publishers, Inc.; 1996:407-427.
2. Thrall JH. Radiopharmaceuticals for endocrine imaging. In. Swanson DP, Chilton HM, Thrall JH, eds Pharmaceuticals in Medical Imaging. New York, NY: Macmillan Publishing Co., Inc.; 1990:343-393.
3. Hladik WB, Ponto JA, Lentle BC, Laven DL. Iatrogenic alterations in the biodistribulion of radiotracers as a result of drug therapy, reported instances. In: Hladik WB, Saha GB, Study KT, eds. Essentials of Nuclear Medicine Science. Baltimore, MD: Williams & Wilkins; 1987:189-219.
4. Chilton HM, Witcofski RL, eds. Nuclear Pharmacy: An Introduction to The Clinical Application of Radiopharmaceuticals. Philadelphia, PA: Lea & Febiger, 1986:94.
5. Powsuer ER, Raeside DE, eds. Diagnostic Nuclear Medicine. New York, NY: Grune & Stratum, Inc.; 1971:400.
6. Datz FL, Patch GG, Anas JM, Morton KA, eds. Nuclear Medicine: A Teaching File. St. Louis, MO: Mosby; 1992:9.
7. Siemsen JK, Telfer N. Nuclear medicine. In: Tubis M, Wolf W, eds. Radiopharmacy. New York, NY: John Wily & Sons; 1976:721-832.
8. Laven DL, Shaw SM. Detection of drug interactions involving radiopharmaceuticals: a professional responsibility of the clinical pharmacist. J Pharm Pract. 1989;2:287-298
9. Bligh AS, Leach KG, Davies ER, eds Radioisotopes in Radiodiagnosis. London, U.K.: Butterworths; 1976:186.
10. Quaife MA, Nagel MV. The endocrine system. In: Bernier DR, Christian PE, Langan JK, Wells LD, eds. Nuclear Medicine Technology and Techniques. St Louis, MO. CV Mosby Co.; 1989:306.
11. Hamilton JG, Soley MH. Studies in iodine metabolism of the thyroid gland in situ by the use of radioiodine in normal subjects and in patients with various types of goiter. Am J Physiol. 1940;131:135-43.
12. Hamilton JG. The use of radioactive tracers in biology and medicine. Radiology 1942;39:541-572.
13. Childs DS, Keating FR, Rall JE, Williams MMD, Power MH. The effect of varying quantities of inorganic iodide (carrier) on the urinary excretion and thyroidal accumulation of radioiodine in exophthalmic goiter J Clin Invest. 1950;29:726-738
14. Sternthal E, Lipworth L, Stanley B, et al. Suppression of thyroid radioiodine uptake by various doses of stable iodide. N Engl J Med. 1980;19:1083-1088.
15. Yu MD. Pharmaceutical Factors that May Affect Diagnostic and Therapeutic Outcomes of Thyroid Disorders [PhD thesis]. West Lafayette, IN: Purdue University School of Pharmacy; May 1998.
16. Langer P. Fluctuation of thyroid function following a single and repeated administration of antithyroid drugs Endocrinology 1968;83:1268-1272.
17. Greer MA. The effect on endogenous thyroid activity of feeding desiccated thyroid to normal human subjects. N Engl J Med. 1951;244:385-390.
18. Grayson RR. Factors which influence the radioactive iodine thyroidal uptake test. Am J Med. 1960;28:397-415.
19. Levy RP, Marshall JS. Short-term drug effects on thyroid function tests. Arch Intern Med. 1964;114:413-416.
20. 131I and plasma protein-bound iodine. J Lab Clin Med 1959;54:53-58.
21. 131I and the serum precipitable iodine in euthyroid persons. N Engl J Med. 1955;253:424-425.
22. Slingerland DW. Effects of an organic iodine compound (Priodax™) on tests of thyroid function. J Clin Endocrinol Memb 1957;17:82-93.
23. 131I uptake in euthyroid patients. J Clin Endocrinol. 1957;17:94-98.
24. 131I after iopanoic acid (Telepaque™) in 74 subjects. J Clin Endocrinol. 1957;17:1008-1010.
25. Jaffiol C, Baldet L, Bada M, Vierne Y. The influence of thyroid function of two iodine-containing radiologie contrast media. Br J Radiol. 1982;55:263-265
26. 131I therapy influences cure rates in hyperthyroidism caused by Graves' disease. Clin Nucl Med 1998;23:810-814.